These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8551265)
1. Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigen. Morand-Joubert L; Bludau H; Lerable J; Petit JC; Lefrère JJ J Med Virol; 1995 Sep; 47(1):87-91. PubMed ID: 8551265 [TBL] [Abstract][Full Text] [Related]
2. Predicting progression of HIV disease: usefulness of acid-dissociated p24 antigen. Morand-Joubert L; Costagliola D; Bludau H; Petit JC; Lefrère JJ J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):676-80. PubMed ID: 8207645 [TBL] [Abstract][Full Text] [Related]
3. Lack of predictive value for progression of dissociated circulating P24 antigen in human immunodeficiency virus type 1-infected black patients. Prazuck T; Troisvallets D; Vallantin X; Patey O; Matta M; Fisch A; Lesguiller C; Si Mohammed A; Thomas M; Lafaix C; Bélec L J Med Virol; 1996 Oct; 50(2):181-7. PubMed ID: 8915885 [TBL] [Abstract][Full Text] [Related]
4. Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Mofenson LM; Harris DR; Rich K; Meyer WA; Read JS; Moye J; Nugent RP; Korelitz J; Bethel J; Pahwa S AIDS; 1999 Jan; 13(1):31-9. PubMed ID: 10207542 [TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological correlates of immune-complex-dissociated HIV-1 p24 antigen in HIV-1-infected children. Duiculescu DC; Geffin RB; Scott GB; Scott WA J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):807-15. PubMed ID: 7912730 [TBL] [Abstract][Full Text] [Related]
6. Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Read JS; Rich KC; Korelitz JJ; Mofenson LM; Harris R; Moye JH; Meyer WA; Pahwa SG; Bethel JW; Nugent RP Pediatr Infect Dis J; 2000 Jun; 19(6):544-51. PubMed ID: 10877171 [TBL] [Abstract][Full Text] [Related]
7. Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time. Farzadegan H; Chmiel JS; Odaka N; Ward L; Poggensee L; Saah A; Phair JP J Infect Dis; 1992 Dec; 166(6):1217-22. PubMed ID: 1358985 [TBL] [Abstract][Full Text] [Related]
8. Western blot banding patterns of HIV rapid progressors in the U.S. Navy Seropositive Cohort: implications for vaccine development. Navy Retroviral Working Group. Garland FC; Garland CF; Gorham ED; Brodine SK Ann Epidemiol; 1996 Jul; 6(4):341-7. PubMed ID: 8876845 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression. Chuenchitra T; Wasi C; Louisirirojchanakul S; Nitayaphan S; Sutthent R; Cox JH; De Souza MS; Brown AE; Birx DL; Polonis VR AIDS Res Hum Retroviruses; 2003 Apr; 19(4):293-305. PubMed ID: 12804005 [TBL] [Abstract][Full Text] [Related]
10. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression. Molina JM; Ferchal F; Chevret S; Barateau V; Poirot C; Morinet F; Modai J AIDS; 1994 Jan; 8(1):27-33. PubMed ID: 7912084 [TBL] [Abstract][Full Text] [Related]
11. Correlation of serum antigen and antibody concentration with clinical features in HIV infection. Ellaurie M; Rubinstein A Arch Dis Child; 1991 Feb; 66(2):200-3. PubMed ID: 1705767 [TBL] [Abstract][Full Text] [Related]
12. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. Hogervorst E; Jurriaans S; de Wolf F; van Wijk A; Wiersma A; Valk M; Roos M; van Gemen B; Coutinho R; Miedema F J Infect Dis; 1995 Apr; 171(4):811-21. PubMed ID: 7706807 [TBL] [Abstract][Full Text] [Related]
13. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression. Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008 [TBL] [Abstract][Full Text] [Related]
14. [Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1]. Laperche S; Maniez-Montreuil M; Couroucé AM Transfus Clin Biol; 2000 Jun; 7 Suppl 1():18s-24s. PubMed ID: 10919219 [TBL] [Abstract][Full Text] [Related]
15. Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection. McRae B; Lange JA; Ascher MS; de Wolf F; Sheppard HW; Goudsmit J; Allain JP AIDS Res Hum Retroviruses; 1991 Aug; 7(8):637-43. PubMed ID: 1931233 [TBL] [Abstract][Full Text] [Related]
16. The Relationship Between HIV Antibody Titer, HIV Viral Load, HIV p24 Antigen, and CD4 T-cell Count Among Iranian HIV-positive Patients. Moradbeigi M; SeyedAlinaghi S; Sajadipour M; Dadras O; Shojaei E; Ahmadi P; Bayanolhagh S; Baesi K; Rasoolinejad M Infect Disord Drug Targets; 2020; 20(5):752-757. PubMed ID: 31682214 [TBL] [Abstract][Full Text] [Related]
17. Immune complex p24 antigen: a new prognostic marker in human immunodeficiency virus infection. Cabezas T; Quirós E; Garcia F; Hernández-Quero J; Bernal MC; Martinez MA; de la Higuera J; Piédrola G; Maroto MC Infection; 1994; 22(1):4-7. PubMed ID: 7910149 [TBL] [Abstract][Full Text] [Related]
18. Specificity of binding of HIV-1 anti-p24 antibodies to CD4+ lymphocytes from HIV-infected subjects. Cameron PU; Hunter SD; Jolley D; Sonza S; Mijch A; Crowe SM Cytometry; 1998 Sep; 33(1):83-8. PubMed ID: 9725562 [TBL] [Abstract][Full Text] [Related]
19. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients. Ercoli L; Sarmati L; el-Sawaf G; Cochi S; Lanti T; Iudicone P; Guglielmetti M; Giannini G; Galluzzo C; Tomino C AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1203-7. PubMed ID: 8573376 [TBL] [Abstract][Full Text] [Related]
20. Alternatives to HIV-RNA and CD4 count to monitor HIV disease progression: a prospective cohort study in Romania. Kozinetz CA; Matusa R; Ruta S; Hacker CS; Cernescu C; Cazacu A J Med Virol; 2005 Oct; 77(2):159-63. PubMed ID: 16121384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]